Acute Tubulointerstitial Nephritis: Clinical Trials

2 trials for Acute Tubulointerstitial Nephritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 2

Follow Acute Tubulointerstitial Nephritis: new trials by email Literature Review of Acute Tubulointerstitial Nephritis trials Research Report on Acute Tubulointerstitial Nephritis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Infliximab for Immune Checkpoint Inhibitor Associated AKI
Infliximab, Prednisone, prednisone (oral) - Acute Kidney Injury, Acute Interstitial Nephritis
Phase 4RecruitingMassachusetts General Hospital442026-09-152026-10-09
Prednisolone Treatment in Acute Interstitial Nephritis
Prednisone - Acute Tubulo-Interstitial Nephritis
Phase 4RecruitingRegion MidtJylland Denmark1102017-09-012020-12-30

Narrower conditions

Acute Kidney Injury (1)

Broader conditions

Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Renal Insufficiency (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Prednisone (2)  ·  Infliximab (1)  ·  Prednisolone (1)

Sponsors

Massachusetts General Hospital (1)  ·  Region MidtJylland Denmark (1)

Countries

Denmark (1)  ·  United States (1)

Top investigators

David Leaf, MD (1)  ·  Jesper N Bech, MD (1)  ·  Meghan E Sise, MD (1)

Results publications

PMID 33933012

NIH funding

R01DK144161 (1)